These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8740016)

  • 1. Danish recommendations for the transfusion of leukocyte-depleted blood components. The Danish Society of Clinical Immunology.
    Vox Sang; 1996; 70(3):185-6. PubMed ID: 8740016
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evidence assurance of transfusion practices. The Danish Society of Clinical Immunology].
    Jørgensen JR; Møller BK
    Ugeskr Laeger; 2004 Mar; 166(12):1112. PubMed ID: 15067771
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical immunology 2002. The Danish Society of Clinical Immunology].
    Hansen MB; Lillevang ST; Møller BK; Varming K; Svejgaard A
    Ugeskr Laeger; 2003 Mar; 165(12):1241. PubMed ID: 12701291
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is the Danish blood transfusion service out of date?].
    Sørensen H
    Ugeskr Laeger; 1995 Jul; 157(27):3879. PubMed ID: 7645059
    [No Abstract]   [Full Text] [Related]  

  • 5. From leukocyte reduction to leukocyte transfusion: the immunological effects of transfused leukocytes.
    Lee JH; Klein HG
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):585-600. PubMed ID: 11102278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood transfusion exposure in Denmark and Sweden.
    Kamper-Jørgensen M; Edgren G; Rostgaard K; Biggar RJ; Nyrén O; Reilly M; Titlestad K; Shanwell A; Melbye M; Hjalgrim H
    Transfusion; 2009 May; 49(5):888-94. PubMed ID: 19210324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leukocyte depletion of blood products: a requirement for improvement of quality and safety].
    De Pauw BE; Van den Bos A
    Ned Tijdschr Geneeskd; 2000 Sep; 144(36):1754-6. PubMed ID: 10992905
    [No Abstract]   [Full Text] [Related]  

  • 9. [Transfusion practice in total hip arthroplasty in Danish departments of orthopaedic surgery].
    Pedersen AB; Mehnert F; Overgaard S; Møller B; Johnsen SP
    Ugeskr Laeger; 2009 Mar; 171(12):973-7. PubMed ID: 19284915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline.
    ; Ferraris VA; Ferraris SP; Saha SP; Hessel EA; Haan CK; Royston BD; Bridges CR; Higgins RS; Despotis G; Brown JR; ; Spiess BD; Shore-Lesserson L; Stafford-Smith M; Mazer CD; Bennett-Guerrero E; Hill SE; Body S
    Ann Thorac Surg; 2007 May; 83(5 Suppl):S27-86. PubMed ID: 17462454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte depletion for safe blood transfusion.
    Singh S; Kumar A
    Biotechnol J; 2009 Aug; 4(8):1140-51. PubMed ID: 19418471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood transfusion. Ugeskrift and the specialty of clinical immunology].
    Kristensen T
    Ugeskr Laeger; 1994 Mar; 156(10):1485-6. PubMed ID: 8016942
    [No Abstract]   [Full Text] [Related]  

  • 13. [A blood transfusion service in a county hospital based upon commercially obtainable reagents].
    Skov F; Schmidt V
    Ugeskr Laeger; 1968 Feb; 130(6):220-6. PubMed ID: 5676288
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical benefits of the leukoreduction of blood products.
    Blajchman MA
    J Trauma; 2006 Jun; 60(6 Suppl):S83-90. PubMed ID: 16763486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force.
    Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of transfusion on viral load in human immunodeficiency virus infection.
    Groopman JE
    Semin Hematol; 1997 Jul; 34(3 Suppl 2):27-33. PubMed ID: 9253781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of two types of leukocyte removal filters on transfusion dependent thalassaemics.
    Jamal R; Mazeni NR; Hussin H
    Malays J Pathol; 2000 Dec; 22(2):79-83. PubMed ID: 16329539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guidelines of the German Medical Association for Therapy with Blood Components and Plasma Derivatives--an introduction. Evidence-based recommendations for the risk-benefit analysis in hemotherapy].
    Heim MU
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Mar; 44(3):186-97; quiz 199. PubMed ID: 19266420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukoreduction of the blood supply in Rhode Island.
    Sweeney JD
    Med Health R I; 1998 Dec; 81(12):386-91. PubMed ID: 9884537
    [No Abstract]   [Full Text] [Related]  

  • 20. [Is Danish donor blood contagious?].
    Georgsen J
    Ugeskr Laeger; 2001 May; 163(19):2613. PubMed ID: 11360352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.